Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises Proteome Sciences plc on placing, subscription and oversubscribed retail offer

Feb 10 2026

Read More
Deal Bird & Bird advises Kersia on the acquisition of part of the business of Polish company Radex

Feb 05 2026

Read More
News Bird & Bird boosts London Competition team with collective action expert Emma Radcliffe

Feb 03 2026

Read More
Deal Bird & Bird advised Search Fund Ulam Transmission on the acquisition of the S.A.M.U. group

Feb 03 2026

Read More
News Bird & Bird expands Energy & Utilities Sector Group with new partner in Munich

Feb 02 2026

Read More
News Bird & Bird boosts Warsaw Commercial team with double partner hire

Jan 30 2026

Read More